Testosterone Undecanoate Capsule Application Results in the Treatment of Male Menopause Syndrome

LUO Wei-cong; HUA Wei; WEN Yan-hua

Abstract：Objective:To discuss Testosterone Undecanoate Capsule(Andriol) application in the treatment of male menopause syndrome.Method:100 cases of male patients with climacteric syndrome from September 2011 to September 2011 in the author’s hospital,using the random number table method were divided into the observation group and control group,50 cases each. Observer group was treated with Testosterone Undecanoate Capsule,the control group was treated with traditional Chinese medicine dialectical for kidney deficiency taking Erxian Soup.Result:Observation group before treatment serum total testosterone levels was (5.04±1.56)nmol/L,rise to eight weeks after the treatment was (8.06±2.97)nmol/L,and the control group before treatment serum total testosterone levels was (4.92±1.78)nmol/L,after 8 weeks after treatment with Erxian Soup was (6.14±2.33)nmol/L,observation group after treatment serum total testosterone levels was higher than that of control group,the difference was statistically significant(P<0.05). Conclusion:In the treatment of male menopause syndrome treated by Testosterone Undecanoate Capsule(Andriol),can significantly improve the patients,male hormones,enhance the level of serum total testosterone and ease of vasomotor symptoms,and is worth popularizing in clinical application.